Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Scheie

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
Acta Neuropathologica Communications|January 4, 2026
Novel insights into meningioma brain invasion with spatial transcriptomic profilingAndrea Daniela Maier, Claes Ottzen Laurentiussen, Signe Regner Michaelsen, et al.
Neurosurgical Review|August 19, 2022
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.
Neuropathology and Applied Neurobiology|November 20, 2021
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningiomaChristian Mirian, Kathrine Grell, Tareq A Juratli, et al.
Plos Genetics|December 17, 2020
Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromesAnna Byrjalsen, Thomas V O Hansen, Ulrik K Stoltze, et al.
Neuropathology and Applied Neurobiology|October 16, 2024
DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centresMihaela Chirica, Philipp Jurmeister, Daniel Teichmann, et al.
Acta Neuropathologica|May 2, 2022
ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significanceAniello Federico, Christian Thomas, Katarzyna Miskiewicz, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
The Journal of Clinical Endocrinology and Metabolism|October 27, 2020
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX MutationsOlivera Casar-Borota, Henning Bünsow Boldt, Britt Edén Engström, et al.
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Journal of Neuro-Oncology|August 5, 2025
The concept, intention, and evaluation of the term treatment-refractory meningiomaLasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Acta Neuropathologica Communications|January 4, 2026
Novel insights into meningioma brain invasion with spatial transcriptomic profilingAndrea Daniela Maier, Claes Ottzen Laurentiussen, Signe Regner Michaelsen, et al.
Neurosurgical Review|August 19, 2022
Somatostatin analogues in treatment-refractory meningioma: a systematic review with meta-analysis of individual patient dataLasse Rehné Jensen, Andrea Daniela Maier, Atle Lomstein, et al.
Neuropathology and Applied Neurobiology|November 20, 2021
Implementation of TERT promoter mutations improve prognostication of the WHO classification in meningiomaChristian Mirian, Kathrine Grell, Tareq A Juratli, et al.
Plos Genetics|December 17, 2020
Nationwide germline whole genome sequencing of 198 consecutive pediatric cancer patients reveals a high incidence of cancer prone syndromesAnna Byrjalsen, Thomas V O Hansen, Ulrik K Stoltze, et al.
Neuropathology and Applied Neurobiology|October 16, 2024
DNA methylation-array interlaboratory comparison trial demonstrates highly reproducible paediatric CNS tumour classification across 13 international centresMihaela Chirica, Philipp Jurmeister, Daniel Teichmann, et al.
Acta Neuropathologica|May 2, 2022
ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significanceAniello Federico, Christian Thomas, Katarzyna Miskiewicz, et al.
NPJ Precision Oncology|March 25, 2023
Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signaturePhilipp Sievers, Martin Sill, Daniel Schrimpf, et al.
The Journal of Clinical Endocrinology and Metabolism|October 27, 2020
Corticotroph Aggressive Pituitary Tumors and Carcinomas Frequently Harbor ATRX MutationsOlivera Casar-Borota, Henning Bünsow Boldt, Britt Edén Engström, et al.
Acta Neuropathologica|August 16, 2019
MYCN amplification drives an aggressive form of spinal ependymomaDavid R Ghasemi, Martin Sill, Konstantin Okonechnikov, et al.
Journal of Neuro-Oncology|August 5, 2025
The concept, intention, and evaluation of the term treatment-refractory meningiomaLasse Rehné Jensen, Andrea Daniela Maier, Tareq A Juratli, et al.
Pageof 12